Finance

Lists
4875:TYO
Medicinova Inc
Â¥227.00
-1.30%
(-3.00) 1D
Sep 2, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4875...
Open
Â¥228
High
Â¥228
Low
Â¥224
Mkt. cap
11.16B
Avg. vol.
40.33K
Volume
27.20K
52-wk high
Â¥314
52-wk low
Â¥174
EPS
-Â¥35
Shares outstanding
41.88M
No. of employees
6
Open
Â¥228
High
Â¥228
Low
Â¥224
Mkt. cap
11.16B
Avg. vol.
40.33K
Volume
27.20K
52-wk high
Â¥314
52-wk low
Â¥174
EPS
-Â¥35
Shares outstanding
41.88M
No. of employees
6
About Medicinova Inc
CEOYuichi Iwaki
Employees6
FoundedSep 26, 2000
HeadquartersLa Jolla, California, United States
SectorBiotechnology
Websitemedicinova.com
Last report
Aug 13, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.05 / -$0.06
+23.08%beat
Revenue / Est. (USD)
458.44K / 75.00K
+511.25%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
123.32K
151.74K
186.98K
458.44K
Cost of goods sold
115.27K
146.98K
170.10K
140.68K
Cost of revenue
115.27K
146.98K
170.10K
140.68K
Research and development expenses
1.58M
1.54M
1.26M
1.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.81M
1.55M
1.59M
1.83M
Operating expense
3.39M
3.10M
2.85M
2.86M
Total operating expenses
3.50M
3.24M
3.02M
3.00M
Operating income
-3.38M
-3.09M
-2.84M
-2.54M
Other non operating income
-10.22K
-5.76K
-3.42K
-4.88K
EBT including unusual items
-3.05M
-2.80M
-2.59M
-2.31M
EBT excluding unusual items
-3.05M
-2.80M
-2.59M
-2.31M
Income tax expense
-
5.99K
-
-
Effective tax rate
-
-0.21%
-
-
Other operating expenses
-
-
-
-
Net income
-3.05M
-2.80M
-2.59M
-2.31M
Net profit margin
-2,473.56%
-1,846.78%
-1,383.14%
-504.79%
Earnings per share
-
-0.05
-0.05
-0.05
Interest and investment income
340.85K
301.88K
252.96K
231.93K
Interest expense
-
-
-
-
Net interest expenses
340.85K
301.88K
252.96K
231.93K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.38M
-3.09M
-2.83M
-2.54M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps